London International Awards

2024 Winners and Finalists

Press Releases Winners Excel Statues/Logos Purchase Awards
Winners & Finalists From:

Filter: Grand LIA Winners Finalists

Bronze
Pharma & Medical
Unbranded: Creative Use of Data

Click a thumbnail to change media.


Previous Entry Next Entry

Back to Results
Entrant: Havas Lynx NY, New York
Brand: Sanofi
Title: "FeNOMENAL"
Corporate Name of Client: Sanofi
Client Company: Sanofi, Cambridge
Client Marketing Directors: April Kelly/Alexander Garcia
Agency: Havas Lynx NY, New York/Havas Health & You Spain, Madrid/Havas NOW, New York
Agency Chief Executive Officer: Alfonso Formariz
Global Chief Creative Officer: Eric Weisberg
Chief Creative Officer: Allison Ceraso
Executive Creative Director: Javier Gomez de Quero del Castillo
Senior Creative Directors: Alex Cho/Rochelle Melton/Ricardo Platón/Raul Lopez
Creative Directors: Nick D'Angelo/Enrique Viejo/José Herrera
Creatives: Raquel Rodrigues/Russell Graf
Agency Creative Technologist: Marc Sallent
Agency Project Manager: Gabriel Santana
Agency Chief Strategy Officer: Maureen Alves
Agency Senior Account Executive: Darrell Ann Matson
Agency Account Supervisor: Elena Kichura
Production Companies: Havas NOW, New York/Prose on Pixels, New York
Producer: Elena Ulloa Loria
Sound Engineer: Andre Nascimbeni
Music Production Company: Score a Score, Los Angeles
Music Supervisor: Damien Escobar
Music Composer: Matt Abeysekera

Description:
The Challenge: Every 10 minutes someone dies from an asthma attack. High FeNO, an underused test to identify airway inflammation, is linked to 3x greater risk of attacks. Although the test is simple, it is not widely used by HCPs or understood by patients. The Brief: Use innovation to drive home the importance of FeNO for asthma control to both doctors and patients, to be piloted in hospitals in Spain, with scalability for other global markets. The Creative Solution: Using custom Data Visualization and Audio Design, the FeNOMENAL experience allows patients to see and hear their own risk, in a way that inspires them to take action. We correlated individual raw scores to an algorithm of shapes, colors, and sounds that turned the lung’s distress into a surround sound sensory experience.

Patients were able to immerse themselves in their own data, providing a compelling and memorable way to learn about what their FeNO score meant.

They were also able to see their own score mapped against others in their region to understand where they stood in the general population. After the experience, they were empowered with tools to bring to their doctor to discuss their score and make a plan. FeNOMENAL partnered with NIOX, global leader in FeNO testing, and with hospitals and advocacy groups across the world to create a new standard for asthma education. The campaign was publicized via social posts, regional hospital internal communications, and advocacy partnerships. The Result: 17% of patients learned they were at risk for an asthma attack, and were empowered to talk with their doctor about a plan that could save their life. FeNOMENAL was Implemented across the world in 4 hospitals and close to a dozen clinical settings, across 3 continents and 4 languages.

The success with patients lead to preceptorships for HCPs so more physicians could learn the value of a FeNO test and change how they identify high risk asthma patients.